Professor Gabrielli completed his undergraduate education at James Cook University in Townsville and PhD at La Trobe University in Melbourne. After two postdoctoral positions in the USA in the emerging field of cell cycle regulation, he was recruited to establish his own independent research at the Queensland Institute of Medical Research, and then recruited to the Diamantina Institute in 2002, and Mater Research Institute in 2016. He is head of the Smiling for Smiddy Cell Cycle Group.
Research Interests
Mechanisms that regulate cell division, particularly progression into mitosis. These mechanisms are often mutated in cancers and are likely to be major contributors to cancer development. Identifying the genetic mutations that disrupt normal progression and particularly mechanisms, known as checkpoints, provides diagnostic and prognostic opportunities. It also provides potential new targets for chemotherapeutics as drugs targeting defective checkpoints have tumour selective cytotoxic potential.
Research Projects
Journal Article: Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas
Zeng, Zhen, Ngo, Hung Long, Proctor, Martina, Rizos, Helen, Dolcetti, Riccardo, Cruz, Jazmina Gonzalez, Wells, James W. and Gabrielli, Brian (2023). Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas. Pigment Cell & Melanoma Research. doi: 10.1111/pcmr.13120
Journal Article: Repurposing of commercially existing molecular target therapies to boost the clinical efficacy of immune checkpoint blockade
Sinha, Debottam, Moseley, Philip, Lu, Xuehan, Wright, Quentin, Gabrielli, Brian, Frazer, Ian H. and Cruz, Jazmina L. G. (2022). Repurposing of commercially existing molecular target therapies to boost the clinical efficacy of immune checkpoint blockade. Cancers, 14 (24) 6150, 1-26. doi: 10.3390/cancers14246150
Journal Article: Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression
Proctor, Martina, Gonzalez Cruz, Jazmina L., Daignault-Mill, Sheena M., Veitch, Margaret, Zeng, Bijun, Ehmann, Anna, Sabdia, Muhammed, Snell, Cameron, Keane, Colm, Dolcetti, Riccardo, Haass, Nikolas K., Wells, James W. and Gabrielli, Brian (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers, 13 (15) 3733, 1-19. doi: 10.3390/cancers13153733
(2023–2026) Ovarian Cancer Research Foundation Research Grants
Enhancing tumour immune detection by targeting replication stress
(2021–2024) Established Investigator
(2018–2020) TRI Spore Grants
Targeting DNA Damage Response Defects in Cancers
(2022) Doctor Philosophy
AURKi enhances replication stress targeted by CHK1i in p53 and RB defective cells
Doctor Philosophy
The Role of Microenvironment in Development of Skin Cancer and Metastasis
(2018) Doctor Philosophy
Identifying the molecular basis for defective checkpoints in melanoma
Targeting defective cell cycle responses to ultraviolet radiation and TopoII inhibitors in melanoma
Defining the molecular changes in moles underpinning morphological changes detectable by non-invasive imaging techniques to improve their diagnostic and prognostic ability for early stage melanoma
Cdc25 family phosphatases in cancer
Gabrielli, Brian and Burgess, Andrew (2016). Cdc25 family phosphatases in cancer. Protein tyrosine phosphatases in cancer. (pp. 283-306) edited by Benjamin G. Neel and Nicholas K. Tonks. New York, USA: Springer New York. doi: 10.1007/978-1-4939-3649-6_11
Spoerri, Loredana, Oo, Zay Yar, Larsen, Jill E., Haass, Nikolas K., Gabrielli, Brian and Pavey, Sandra (2015). Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.. Stress response pathways in cancer: from molecular targets to novel therapeutics. (pp. 29-49) edited by Georg T. Wondrak. Dordrecht: Springer Science+Business Media. doi: 10.1007/978-94-017-9421-3_3
Gabrielli, Brian G., Stevens, Frances and Beamish, Heather J. (2008). Do Histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?. Checkpoint responses in cancer therapy. (pp. 291-309) edited by Wei Dai. The United States of America: Humana Press. doi: 10.1007/978-1-59745-274-8
Cell Cycle Targets of Histone Deacetylase Inhibitors
Gabrielli, Brian (2006). Cell Cycle Targets of Histone Deacetylase Inhibitors. Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions. (pp. 299-314) edited by Eric Verdin. Berlin: Humana Press.
Histone Deacetylase Inhibition as a Treatment of TRAIL-Resistant Cancers
Neuzil, J., Andera, L. and Gabrielli, B. (2005). Histone Deacetylase Inhibition as a Treatment of TRAIL-Resistant Cancers. Application of Apoptosis to Cancer Treatment. (pp. 271-291) edited by Mels Sluyser. Netherlands: Springer. doi: 10.1007/1-4020-3302-8_12
Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors
Beamish, Heather, Warrener, Robyn and Gabrielli, Brian G. (2004). Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors. Checkpoint Controls and Cancer: Vol. 2: Activation and Regulation Protocols. (pp. 245-259) edited by Axel H. Schonthal. Totowa, N.J.: Humana Press. doi: 10.1226/1588295001
Zeng, Zhen, Ngo, Hung Long, Proctor, Martina, Rizos, Helen, Dolcetti, Riccardo, Cruz, Jazmina Gonzalez, Wells, James W. and Gabrielli, Brian (2023). Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas. Pigment Cell & Melanoma Research. doi: 10.1111/pcmr.13120
Sinha, Debottam, Moseley, Philip, Lu, Xuehan, Wright, Quentin, Gabrielli, Brian, Frazer, Ian H. and Cruz, Jazmina L. G. (2022). Repurposing of commercially existing molecular target therapies to boost the clinical efficacy of immune checkpoint blockade. Cancers, 14 (24) 6150, 1-26. doi: 10.3390/cancers14246150
Proctor, Martina, Gonzalez Cruz, Jazmina L., Daignault-Mill, Sheena M., Veitch, Margaret, Zeng, Bijun, Ehmann, Anna, Sabdia, Muhammed, Snell, Cameron, Keane, Colm, Dolcetti, Riccardo, Haass, Nikolas K., Wells, James W. and Gabrielli, Brian (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers, 13 (15) 3733, 1-19. doi: 10.3390/cancers13153733
Fernando, Madushan, Duijf, Pascal H. G., Proctor, Martina, Stevenson, Alexander J., Ehmann, Anna, Vora, Shivam, Skalamera, Dubravka, Adams, Mark and Gabrielli, Brian (2021). Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours. Oncogenesis, 10 (5) 41, 41. doi: 10.1038/s41389-021-00329-8
Unexpected high levels of BRN2/POU3F2 expression in human dermal melanocytic nevi
Chitsazan, Arash, Lambie, Duncan, Ferguson, Blake, Handoko, Herlina Y., Gabrielli, Brian, Walker, Graeme J. and Boyle, Glen M. (2020). Unexpected high levels of BRN2/POU3F2 expression in human dermal melanocytic nevi. Journal of Investigative Dermatology, 140 (6), 1299-1302.e4. doi: 10.1016/j.jid.2019.12.007
Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts
Škalamera, Dubravka, Stevenson, Alexander J., Ehmann, Anna, Ainger, Stephen A., Lanagan, Catherine, Sturm, Richard A. and Gabrielli, Brian (2019). Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts. Journal of Cell Science, 132 (24) jcs234716, jcs234716. doi: 10.1242/jcs.234716
Pavey, Sandra, Pinder, Alex, Fernando, Winnie, D'Arcy, Nicholas, Matigian, Nicholas, Skalamera, Dubravka, Lê Cao, Kim-Anh, Loo-Oey, Dorothy, Hill, Michelle M., Stark, Mitchell, Kimlin, Michael, Burgess, Andrew, Cloonan, Nicole, Sturm, Richard A. and Gabrielli, Brian (2019). Multiple interaction nodes define the post-replication repair response to UV-induced DNA damage that is defective in melanomas and correlated with UV signature mutation load. Molecular Oncology, 14 (1) 1878-0261.12601, 22-41. doi: 10.1002/1878-0261.12601
Everything in moderation: lessons learned by exploiting moderate replication stress in cancer
Nazareth, Deborah, Jones, Matthew J.K. and Gabrielli, Brian (2019). Everything in moderation: lessons learned by exploiting moderate replication stress in cancer. Cancers, 11 (9) 1320, 1320. doi: 10.3390/cancers11091320
Oo, Zay Yar, Proctor, Martina, Stevenson, Alexander J., Nazareth, Deborah, Fernando, Madushan, Daignault, Sheena M., Lanagan, Catherine, Walpole, Sebastian, Bonazzi, Vanessa, Škalamera, Dubravka, Snell, Cameron, Haass, Nikolas K., Larsen, Jill E. and Gabrielli, Brian (2019). Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine. Molecular Oncology, 13 (7) 1878-0261.12497, 1503-1518. doi: 10.1002/1878-0261.12497
Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers
Shaikh, Mushfiq H., Idris, Adi, Johnson, Newell W., Fallaha, Sora, Clarke, Daniel T.W., Martin, David, Morgan, Iain M., Gabrielli, Brian and McMillan, Nigel A. J. (2018). Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers. Oral Oncology, 86, 105-112. doi: 10.1016/j.oraloncology.2018.09.006
D’Arcy, Nicholas, Matigian, Nicholas, Lê Cao, Kim-Anh and Gabrielli, Brian (2018). Pathway dysregulation analysis of the nucleotide excision repair mechanisms reveals it is not a common feature of melanomas. Pigment Cell & Melanoma Research, 32 (2), 336-338. doi: 10.1111/pcmr.12740
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
Kalimutho, Murugan, Sinha, Debottam, Jeffery, Jessie, Nones, Katia, Srihari, Sriganesh, Fernando, Winnie C., Duijf, Pascal H. G., Vennin, Claire, Raninga, Prahlad, Nanayakkara, Devathri, Mittal, Deepak, Saunus, Jodi M., Lakhani, Sunil R., López, J Alejandro, Spring, Kevin J., Timpson, Paul, Gabrielli, Brian, Waddell, Nicola and Khanna, Kum Kum (2018). CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer. EMBO Molecular Medicine, 10 (9) e8566, e8566. doi: 10.15252/emmm.201708566
Endogenous replication stress marks melanomas sensitive to CHEK1 inhibitors in vivo
Oo, Zay Yar, Stevenson, Alexander J., Proctor, Martina A., Daignault, Sheena M., Walpole, Sebastian, Lanagan, Catherine, Chen, James, Skalamera, Dubravka, Spoerri, Loredana, Ainger, Stephen, Sturm, Richard A, Haass, Nikolas K and Gabrielli, Brian (2018). Endogenous replication stress marks melanomas sensitive to CHEK1 inhibitors in vivo. Clinical Cancer Research, 24 (12), 2901-2912. doi: 10.1158/1078-0432.CCR-17-2701
Stevenson, Alexander J., Ager, Eleanor I., Proctor, Martina A., Škalamera, Dubravka, Heaton, Andrew, Brown, David and Gabrielli, Brian G. (2018). Mechanism of action of the third generation benzopyrans and evaluation of their broad anti-cancer activity in vitro and in vivo. Scientific Reports, 8 (1) 22882, 5144. doi: 10.1038/s41598-018-22882-w
Levrier, Claire, Rockstroh, Anja, Gabrielli, Brian, Kavallaris, Maria, Lehman, Melanie, Davis, Rohan A, Sadowski, Martin C and Nelson, Colleen C (2018). Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells. Cell Cycle, 17 (5), 652-668. doi: 10.1080/15384101.2017.1356512
Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers
Hammerlindl, Heinz, Ravindran Menon, Dinoop, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens and Schaider, Helmut (2018). Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers. Clinical Cancer Research, 24 (5), 1090-1102. doi: 10.1158/1078-0432.CCR-16-2118
Distinct histone modifications denote early stress-induced drug tolerance in cancer
Emran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard and Schaider, Helmut (2017). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget, 9 (9), 8206-8222. doi: 10.18632/oncotarget.23654
Chitsazan, Arash, Ferguson, Blake, Villani, Rehan, Handoko, Herlina Y, Mukhopadhyay, Pamela, Gabrielli, Brian, Mooi, Wolter J, Soyer, H Peter, Lambie, Duncan, Khosrotehrani, Kiarash, Morahan, Grant and Walker, Graeme J (2017). Keratinocyte sonic hedgehog up-regulation drives the development of giant congenital nevi via paracrine endothelin-1 secretion. The Journal of investigative dermatology, 138 (4), 893-902. doi: 10.1016/j.jid.2017.10.032
Martin, David, Fallaha, Sora, Proctor, Martina, Stevenson, Alexander, Perrin, Lewis, McMillan, Nigel and Gabrielli, Brian (2017). Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors. Molecular Cancer Therapeutics, 16 (9), 1934-1941. doi: 10.1158/1535-7163.MCT-17-0159
Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities
Haass, Nikolas K. and Gabrielli, Brian (2017). Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities. Experimental Dermatology, 26 (7), 649-655. doi: 10.1111/exd.13303
Lee, Won Jae, Skalamera, Dubravka, Dahmer-Heath, Mareike, Shakhbazov, Konstanin, Ranall, Max V., Fox, Carly, Lambie, Duncan, Stevenson, Alexander J., Yaswen, Paul, Gonda, Thomas J. and Gabrielli, Brian (2017). Genome-wide overexpression screen identifies genes able to bypass p16-mediated senescence in melanoma. SLAS Discovery, 22 (3), 298-308. doi: 10.1177/1087057116679592
Levrier, Claire, Sadowski, Martin C., Rockstroh, Anja, Gabrielli, Brian, Kavallaris, Maria, Lehman, Melanie, Davis, Rohan A. and Nelson, Colleen C. (2017). 6α-Acetoxyanopterine: a novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells. Molecular Cancer Therapeutics, 16 (1), 3-15. doi: 10.1158/1535-7163.MCT-16-0325
Topoisomerase II inhibitors and poisons, and the influence of cell cycle checkpoints
D'Arcy, Nicholas and Gabrielli, Brian (2017). Topoisomerase II inhibitors and poisons, and the influence of cell cycle checkpoints. Current Medicinal Chemistry, 24 (15), 1504-1519. doi: 10.2174/0929867323666161205122613
Skalamera, Dubravka, Dahmer-Heath, Mareike, Stevenson, Alexander J., Pinto, Cletus, Shah, Esha T., Daignault, Sheena M., Said, Nur Akmarina B. M., Davis, Melissa, Haass, Nikolas K., Williams, Elizabeth D., Hollier, Brett G., Thompson, Erik W., Gabrielli, Brian and Gonda, Thomas J. (2016). Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer. Oncotarget, 7 (38), 61000-61020. doi: 10.18632/oncotarget.11314
Fox, Carly, Lambie, Duncan, Wilmott, James S., Pinder, Alex, Pavey, Sandra, Lê Cao, Kim-Anh, Akalin, Taner, Karaarslan, Isil Kilinc, Ozdemir, Fezal, Scolyer, Richard A., Yamada, Miko, Soyer, H. Peter, Schaider, Helmut and Gabrielli, Brian (2016). Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation. Pigment Cell and Melanoma Research, 29 (4), 444-452. doi: 10.1111/pcmr.12489
A mutation in the Cdon gene potentiates congenital nevus development mediated by NRASQ61K
Chitsazan, Arash, Ferguson, Blake, Ram, Ramesh, Mukhopadhyay, Pamela, Handoko, Herlina Y., Gabrielli, Brian, Soyer, Peter H, Morahan, Grant and Walker, Graeme J. (2016). A mutation in the Cdon gene potentiates congenital nevus development mediated by NRASQ61K. Pigment Cell and Melanoma Research, 29 (4), 459-464. doi: 10.1111/pcmr.12487
Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells
Beaumont, Kimberley A., Hill, David S., Daignault, Sheena M., Lui, Goldie Y. L., Sharp, Danae M., Gabrielli, Brian, Weninger, Wolfgang and Haass, Nikolas K. (2016). Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells. Journal of Investigative Dermatology, 136 (7), 1479-1489. doi: 10.1016/j.jid.2016.02.805
Spoerri, Loredana, Brooks, Kelly, Chia, KeeMing, Grossman, Gavriel, Ellis, Jonathan J., Dahmer-Heath, Mareike, Skalamera, Dubravka, Pavey, Sandra, Burmeister, Bryan and Gabrielli, Brian (2016). A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma. Pigment Cell and Melanoma Research, 29 (3), 329-339. doi: 10.1111/pcmr.12466
In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis
Vaidyanathan, Srividya, Cato, Kathleen, Tang, Lu, Pavey, Sandra, Haass, Nikolas K., Gabrielli, Brian G. and Duijf, Pascal H. G. (2016). In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis. Oncogene, 35 (41), 5446-5455. doi: 10.1038/onc.2016.94
Patel, Jatin, Wong, Ho Yi, Wang, Weili, Alexis, Josue, Shafiee, Abbas, Stevenson, Alexander J., Gabrielli, Brian, Fisk, Nicholas M. and Khosrotehrani, Kiarash (2016). Self-renewal and high proliferative colony forming capacity of late-outgrowth endothelial progenitors is regulated by cyclin-dependent kinase inhibitors driven by notch signaling. Stem Cells, 34 (4), 902-912. doi: 10.1002/stem.2262
Harrington, Brittney S., He, Yaowu, Davies, Claire M., Wallace, Sarah J., Adams, Mark N., Beaven, Elizabeth A., Roche, Deborah K., Kennedy, Catherine, Chetty, Naven P., Crandon, Alexander J., Flatley, Christopher, Oliveira, Niara B., Shannon, Catherine M., deFazio, Anna, Tinker, Anna V., Gilks, C. Blake, Gabrielli, Brian, Brennan, Donal J., Coward, Jermaine I., Armes, Jane E., Perrin, Lewis C. and Hooper, John D. (2016). Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer. British Journal of Cancer, 114 (4), 417-426. doi: 10.1038/bjc.2015.471
A distinct expression profile separates Turkish and Australian melanocytic naevi
Fox, Carly, Schaider, Helmut, Akalin, Taner, Turkmen, Meltem, Sturm, Rick, Lambie, Duncan, Karaarslan, Isil K., Soyer, H. Peter, Ozdemir, Fezal and Gabrielli, Brian (2016). A distinct expression profile separates Turkish and Australian melanocytic naevi. Histopathology, 69 (1), 151-154. doi: 10.1111/his.12906
Aurora A is critical for survival in HPV-transformed cervical cancer
Gabrielli, Brian, Bokhari, Fawzi, Ranall, Max V., Oo, Zay Yar, Stevenson, Alexander J., Wang, Weili, Murrell, Melanie, Shaikh, Mushfiq, Fallaha, Sora, Clarke, Daniel, Kelly, Madison, Sedelies, Karin, Christensen, Melinda, McKee, Sara, Leggatt, Graham, Leo, Paul, Skalamera, Dubravka, Soyer, H. Peter, Gonda, Thomas J. and McMillan, Nigel A. J. (2015). Aurora A is critical for survival in HPV-transformed cervical cancer. Molecular Cancer Therapeutics, 14 (12), 2753-2761. doi: 10.1158/1535-7163.MCT-15-0506
A stress-induced early innate response causes multidrug tolerance in melanoma
Ravindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Bonyadi Rad, E., Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). A stress-induced early innate response causes multidrug tolerance in melanoma. Oncogene, 34 (34), 4448-4459. doi: 10.1038/onc.2014.372
Menon, D. Ravindran, Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015). Oncogene, 34 (34), 4545-4545. doi: 10.1038/onc.2014.432
JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase
Pinder, Alex, Loo, Dorothy, Harrington, Brittney, Oakes, Vanessa, Hill, Michelle M. and Gabrielli, Brian (2015). JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. Cellular Signalling, 27 (11), 2296-2303. doi: 10.1016/j.cellsig.2015.08.009
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
Irvine, Katharine M., Skoien, Richard, Bokil, Nilesh J., Melino, Michelle, Thomas, Gethin P., Loo, Dorothy, Gabrielli, Brian, Hill, Michelle M., Sweet, Matthew J., Clouston, Andrew D. and Powell, Elizabeth E. (2014). Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World Journal of Gastroenterology, 20 (47), 17851-17862. doi: 10.3748/wjg.v20.i47.17851
DCT protects human melanocytic cells from UVR and ROS damage and increases cell viability
Ainger, Stephen A., Yong, Xuan L., Wong, Shu S., Skalamera, Dubravka, Gabrielli, Brian, Leonard, J. Helen and Sturm, Richard A. (2014). DCT protects human melanocytic cells from UVR and ROS damage and increases cell viability. Experimental Dermatology, 23 (12), 916-921. doi: 10.1111/exd.12574
Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle
Oakes, Vanessa, Wang, Weili, Harrington, Brittney, Lee, Won Jae, Beamish, Heather, Chia, Kee Ming, Pinder, Alex, Goto, Hidemasa, Inagaki, Masaki, Pavey, Sandra and Gabrielli, Brian (2014). Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle. Cell Cycle, 13 (20), 3302-3311. doi: 10.4161/15384101.2014.949111
Decatenation checkpoint defective melanomas are dependent on PI3K for survival
Brooks, Kelly, Ranall, Max, Spoerri, Loredana, Stevenson, Alex, Gunasingh, Gency, Pavey, Sandra, Meunier, Fred, Gonda, Thomas J. and Gabrielli, Brian (2014). Decatenation checkpoint defective melanomas are dependent on PI3K for survival. Pigment Cell and Melanoma Research, 27 (5), 813-821. doi: 10.1111/pcmr.12268
Sierecki, Emma, Stevers, Loes M., Giles, Nichole, Polinkovsky, Mark E., Moustaqil, Mehdi, Mureev, Sergey, Johnston, Wayne A., Dahmer-Heath, Mareike, Skalamera, Duka, Gonda, Thomas J., Gabrielli, Brian, Collins, Brett M., Alexandrov, Kirill and Gambin, Yann (2014). Rapid mapping of interactions between human SNX-BAR proteins measured in vitro by AlphaScreen and single-molecule spectroscopy. Molecular and Cellular Proteomics, 13 (9), 2233-2245. doi: 10.1074/mcp.M113.037275
Sturm, Richard A., Fox, Carly, McClenahan, Phil, Jagirdar, Kasturee, Ibarrola-Villava, Maider, Banan, Parastoo, Abbott, Nicola C., Ribas, Gloria, Gabrielli, Brian, Duffy, David L. and Soyer, H. Peter (2014). Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients. Journal of Investigative Dermatology, 134 (1), 141-149. doi: 10.1038/jid.2013.272
DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.
Pavey, Sandra, Spoerri, Loredana, Haass, Nikolas K. and Gabrielli, Brian (2013). DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.. Pigment Cell and Melanoma Research, 26 (6), 805-816. doi: 10.1111/pcmr.12136
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci
Boutros, Rose, Mondesert, Odile, Lorenzo, Corinne, Astuti, Puji, McArthur, Grant, Chircop, Megan, Ducommun, Bernard and Gabrielli, Brian (2013). CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci. PLoS One, 8 (7) e67822, e67822.1-e67822.13. doi: 10.1371/journal.pone.0067822
Defective decatenation checkpoint function is a common feature of melanoma
Brooks, Kelly, Chia, Kee Ming, Spoerri, Loredana, Mukhopadhyay, Pamela, Wigan, Matthew, Stark, Mitchell, Pavey, Sandra and Gabrielli, Brian (2013). Defective decatenation checkpoint function is a common feature of melanoma. Journal of Investigative Dermatology, 134 (1), 150-158. doi: 10.1038/jid.2013.264
Small, David M., Bennett, Nigel C., Roy, Sandrine, Gabrielli, Brian G., Johnson, David W. and Gobe, Glenda C. (2013). Oxidative stress and cell senescence combine to cause maximal renal Tubular Epithelial Cell Dysfunction and loss in an in vitro Model of Kidney Disease. Nephron Experimental Nephrology, 122 (3-4), 123-130. doi: 10.1159/000350726
Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells
Pike, Tanya, Widberg, Charlotte, Goodall, Andrew, Payne, Elizabeth, Giles, Nichole, Hancock, John and Gabrielli, Brian (2013). Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells. Cellular Signalling, 25 (6), 1423-1428. doi: 10.1016/j.cellsig.2013.03.014
Similar, not the same: diverse roles and regulation of cyclin Es
Spoerri, Loredana and Gabrielli, Brian (2013). Similar, not the same: diverse roles and regulation of cyclin Es. Cell Cycle, 12 (5), 715-715. doi: 10.4161/cc.23909
A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress
Brooks, K., Oakes, V., Edwards, B., Ranall, M., Leo, P., Pavey, S., Pinder, A., Beamish, H., Mukhopadhyay, P., Lambie, D. and Gabrielli, B. (2013). A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress. Oncogene, 32 (6), 788-796. doi: 10.1038/onc.2012.72
MicroRNA-182-5-p targets a network of genes involved in DNA repair
Krishnan, Keerthana, Steptoe, Anita L., Martin, Hilary C., Wani, Shivangi, Nones, Katia, Waddell, Nic, Mariasegaram, Mythily, Simpson, Peter T., Lakhani, Sunil R., Gabrielli, Brian, Vlassov, Alexander, Cloonan, Nicole and Grimmond, Sean M. (2013). MicroRNA-182-5-p targets a network of genes involved in DNA repair. RNA, 19 (2), 230-242. doi: 10.1261/rna.034926.112
Skalamera, Dubravka, Dahmer, Mareike, Purdon, Amy S., Wilson, Benjamin M., Ranall, Max V., Blumenthal, Antje, Gabrielli, Brian and Gonda, Thomas J. (2012). Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of hman ORFs and identification of human genes affecting viral titer. PloS One, 7 (12) e51733, e51733.1-e51733.15. doi: 10.1371/journal.pone.0051733
Wigan, Matthew, Pinder, Alex, Giles, Nichole, Pavey, Sandra, Burgess, Andrew, Wong, ShuShyan, Sturm, Rick A. and Gabrielli, Brian (2012). A UVR-induced G2-phase checkpoint response to ssDNA gaps produced by replication fork bypass of unrepaired lesions is defective in melanoma. Journal of Investigative Dermatology, 132 (6), 1681-1688. doi: 10.1038/jid.2012.41
Keeping replicative stress in Chk
Brooks, Kelly and Gabrielli, Brian (2012). Keeping replicative stress in Chk. Cell Cycle, 11 (11), 2039-2040. doi: 10.4161/cc.20425
Defective cell cycle checkpoints as targets for anti-cancer therapies
Gabrielli, Brian, Brooks, Kelly and Pavey, Sandra (2012). Defective cell cycle checkpoints as targets for anti-cancer therapies. Frontiers in Pharmacology, 3 (9) 9, 9.1-9.6. doi: 10.3389/fphar.2012.00009
Giles, N., Pavey, S., Pinder, A. and Gabrielli, B. (2012). Multiple melanoma susceptibility factors function in an ultraviolet radiation response pathway in skin. British Journal of Dermatology, 166 (2), 362-371. doi: 10.1111/j.1365-2133.2011.10635.x
Gabrielli, Brian and Brown, Melissa (2012). Histone deacetylase inhibitors disrupt the mitotic spindle assembly checkpoint by targeting histone and nonhistone proteins. Advances in Cancer Research, 116, 1-37. doi: 10.1016/B978-0-12-394387-3.00001-X
Histone deacetylase inhibitors in the generation of the anti-tumour immune response
Leggatt, Graham R. and Gabrielli, Brian (2012). Histone deacetylase inhibitors in the generation of the anti-tumour immune response. Immunology and Cell Biology, 90 (1), 33-38. doi: 10.1038/icb.2011.94
Finally, how histone deacetylase inhibitors disrupt mitosis!
Gabrielli, Brian, Chia, KeeMing and Warrener, Robyn (2011). Finally, how histone deacetylase inhibitors disrupt mitosis!. Cell Cycle, 10 (16), 2658-2661. doi: 10.4161/cc.10.16.16953
High-content imaging of neutral lipid droplets with 1,6-diphenylhexatriene
Ranall, Max V., Gabrielli, Brian g. and Gonda, Thomas J. (2011). High-content imaging of neutral lipid droplets with 1,6-diphenylhexatriene. Biotechniques, 51 (1), 35-42. doi: 10.2144/000113702
Phosphorylation of Cdc25B3 Ser169 regulates 14-3-3 binding to Ser151 and Cdc25B activity
Astuti, Puji and Gabrielli, Brian (2011). Phosphorylation of Cdc25B3 Ser169 regulates 14-3-3 binding to Ser151 and Cdc25B activity. Cell Cycle, 10 (12), 1960-1967. doi: 10.4161/cc.10.12.15819
A high-throughput platform for lentiviral overexpression screening of the human ORFeome
Škalamera, Dubravka, Ranall, Max V., Wilson, Benjamin M., Leo, Paul, Purdon, Amy S., Hyde, Carolyn, Nourbakhsh, Ehsan, Grimmond, Sean M., Barry, Simon C., Gabrielli, Brian and Gonda, Thomas J. (2011). A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PLoS One, 6 (5) e20057, e20057.1-e20057.14. doi: 10.1371/journal.pone.0020057
Evidence for label-retaining tumour-initiating cells in human glioblastoma
Deleyrolle, Loic P., Harding, Angus, Cato, Kathleen, Siebzehnrubl, Florian A., Rahman, Maryam, Azari, Hassan, Olson, Sarah, Gabrielli, Brian, Osborne, Geoffrey, Vescovi, Angelo and Reynolds, Brent A. (2011). Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain, 134 (5), 1331-1343. doi: 10.1093/brain/awr081
Boutros, Rose, Lorenzo, Corinne, Mondesert, Odile, Jauneau, Alain, Oakes,Vanessa, Dozier, Christine, Gabrielli, Brian and Ducommun, Bernard (2011). CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity. Biology of the Cell, 103 (2), 55-68. doi: 10.1042/BC20100111
Astuti, P, Boutros, R, Ducommun, B and Gabrielli, B (2010). Mitotic phosphorylation of Cdc25B Ser(321) disrupts 14-3-3 binding to the high affinity Ser(323) site. Journal of Biological Chemistry, 285 (45), 34364-34370. doi: 10.1074/jbc.M110.138412
Warrener, Robyn, Chia, KeeMing, Warren, William D., Brooks, Kelly and Gabrielli, Brian (2010). Inhibition of histone deacetylase 3 produces mitotic defects independent of alterations in histone H3 lysine 9 acetylation and methylation. Molecular Pharmacology, 78 (3), 384-393. doi: 10.1124/mol.109.062976
The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtubule inhibitory activity
Chia, K, Beamish, H, Jafferi, K and Gabrielli, B (2010). The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtubule inhibitory activity. Molecular Pharmacology, 78 (3), 436-443. doi: 10.1124/mol.110.065169
Ranall, Max V., Gabrielli, Brian G. and Gonda, Thomas J. (2010). Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high throughput screening. BioTechniques, 48 (5), 379-386. doi: 10.2144/000113410
MAPK pathway activation delays G(2)/M progression by destabilizing Cdc25B
Astuti, P, Pike, T, Widberg, C, Payne, E, Harding, A, Hancock, J and Gabrielli, B (2009). MAPK pathway activation delays G(2)/M progression by destabilizing Cdc25B. Journal of Biological Chemistry, 284 (49), 33781-33788. doi: 10.1074/jbc.M109.027516
Cyclin A/cdk2 regulates adenomatous polyposis coli-dependent mitotic spindle anchoring
Beamish, Heather, De Boer, Leonore, Giles, Nichole, Stevens, Frankie, Oakes, Vanessa and Gabrielli, Brian (2009). Cyclin A/cdk2 regulates adenomatous polyposis coli-dependent mitotic spindle anchoring. Journal of Biological Chemistry, 284 (42), 29015-29023. doi: 10.1074/jbc.M109.042820
CtBPs promote cell survival through the maintenance of mitotic fidelity
Bergman, Lee M., Birts, Charles N., Darley, Matthew, Gabrielli, Brian and Blaydes, Jeremy P. (2009). CtBPs promote cell survival through the maintenance of mitotic fidelity. Molecular and Cellular Biology, 29 (16), 4539-4551. doi: 10.1128/MCB.00439-09
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Cloonan, Nicole, Brown, Mellissa K., Steptoe, Anita L., Wani, Shivangi, Chan, Wei Ling, Forrest, Alistair R. R., Kolle, Gabriel, Gabrielli, Brian and Grimmond, Sean M. (2008). The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biology, 9 (8) R127, R127.1-R127.14. doi: 10.1186/gb-2008-9-8-r127
Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events
De Boer, L., Oakes, V., Beamish, H., Giles, N., Stevens, F., Somodevilla Torres, M., DeSouza, C. and Gabrielli, B. (2008). Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene, 27 (31), 4261-4268. doi: 10.1038/onc.2008.74
Histone deacetylase inhibitors induce mitotic slippage
Stevens, Frances, Beamish, Heather J., Robyn Warrener and Gabrielli, Brian G. (2008). Histone deacetylase inhibitors induce mitotic slippage. Oncogene, 27 (10), 1345-1354. doi: 10.1038/sj.onc.1210779
Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells
Gabrielli, B., Chau, Y. Q., Giles, N., Harding, A., Stevens, F. and Beamish, H. (2007). Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells. The Journal of Biological Chemistry, 282 (10), 6954-6964. doi: 10.1074/jbc.M610104200
Inhibition of S/G(2) phase CDK4 reduces mitotic fidelity
Burgess, A, Wigan, M, Giles, N, DePinto, W, Gillespie, P, Stevens, F and Gabrielli, B (2006). Inhibition of S/G(2) phase CDK4 reduces mitotic fidelity. Journal of Biological Chemistry, 281 (15), 9987-9995. doi: 10.1074/jbc.M512714200
Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4(R24C/R24C)/TPras mice
Hacker, E., Muller, H. K., Irwin, N., Gabrielli, B., Lincoin, D., Pavey, S., Powell, M. B., Malumbres, M., Barbacid, M., Hayward, N. and Walker, G. (2006). Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4(R24C/R24C)/TPras mice. Cancer Research, 66 (6), 2946-2952. doi: 10.1158/0008-5472.CAN-05-3196
Fabbro, Megan, Zhou, Bin-Bing, Takahasi, Mikiko, Sarcevic, Boris, Lal, Preeti, Graham, Mark E., Gabrielli, Brian G., Robinson, Phillip J., Nigg, Erich A., Ono, Yoshitaka and Khanna, Kum Kum (2005). Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Developmental Cell, 9 (4), 477-488. doi: 10.1016/j.devcel.2005.09.003
Putral, L. N., Bywater, M. J., Gu, W. Y., Saunders, N. A., Gabrielli, B. G., Leggatt, G. R. and McMillan, N. A. J. (2005). RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Molecular Pharmacology, 68 (5), 1311-1319. doi: 10.1124/mol.105.014191
Histone-deacetylase inhibitors for the treatment of cancer
Lindemann, Ralph K., Gabrielli, Brian G. and Johnstone, Ricky W. (2004). Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle, 3 (6), 779-788. doi: 10.4161/cc.3.6.927
Analysis of checkpoint responses to histone deacetylase inhibitors
Beamish, Heather, Warrener, Robyn and Gabrielli, Brian G (2004). Analysis of checkpoint responses to histone deacetylase inhibitors. Methods in molecular biology (Clifton, N.J.), 281, 245-259. doi: 10.1385/1-59259-811-0:245
Analyzing checkpoint controls in human skin
Pavey, S. and Gabrielli, B. G. (2004). Analyzing checkpoint controls in human skin. Methods in Molecular Biology, 280 (1), 175-183.
Defining the chemotherapeutic targets of Histone Deacetylase inhibitors
Gabrielli, B. G., Warrener, R. M., Burgess, A. J. and Beamish, H. J. (2004). Defining the chemotherapeutic targets of Histone Deacetylase inhibitors. Annals New York Academy of Sciences, 1030, 627-635. doi: 10.1196/annals.1329.073
Histone deacetylase inhibitors specifically kill nonproliferating tumour cells
Burgess, Andrew, Ruefli, Astrid, Beamish, Heather, Warrener, Robyn, Saunders, Nicholas, Johnstone, Ricky and Gabrielli, Brian (2004). Histone deacetylase inhibitors specifically kill nonproliferating tumour cells. Oncogene, 23 (40), 6693-6701. doi: 10.1038/sj.onc.1207893
The EBNA- 3 gene family proteins disrupt the G2/M checkpoint
Krauer, Kenia G., Burgess, Andrew, Buck, Marion, Flanagan, James, Sculley, Tom B. and Gabrielli, Brian (2004). The EBNA- 3 gene family proteins disrupt the G2/M checkpoint. Oncogene, 23 (7), 1342-1353. doi: 10.1038/sj.onc.1207253
14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity
Giles, N., Forrest, A. and Gabrielli, B. (2003). 14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity. Journal of Biological Chemistry, 278 (31), 28580-28587. doi: 10.1074/jbc.M304027200
APC mutation and tumour budding in colorectal cancer
Jass, JR, Barker, M, Fraser, L, Walsh, MD, Whitehall, VLJ, Gabrielli, B, Young, J and Leggett, BA (2003). APC mutation and tumour budding in colorectal cancer. Journal of Clinical Pathology, 56 (1), 69-73. doi: 10.1136/jcp.56.1.69
Mechanism of mitosis-specific activation of MEK1
Harding, A., Giles, N., Burgess, A., Hancock, J. F. and Gabrielli, B. G. (2003). Mechanism of mitosis-specific activation of MEK1. Journal of Biological Chemistry, 278 (19), 16747-16754. doi: 10.1074/jbc.M301015200
Tumor cell-specific cytotoxicity by targeting cell cycle checkpoints
Warrener, R, Beamish, H, Burgess, A, Waterhouse, NJ, Giles, N, Fairlie, DP and Gabrielli, B (2003). Tumor cell-specific cytotoxicity by targeting cell cycle checkpoints. Faseb Journal, 17 (9), 1550-1570. doi: 10.1096/fj.02-1003fje
Gabrielli, B. G., Johnstone, R. W. and Saunders, N. A. (2002). Identifying molecular targets mediating the anticancer activity of histone deacetylase inhibitors: A work in progress. Current Cancer Drug Targets, 2 (4), 337-353. doi: 10.2174/1568009023333818
Sculley, T. B., Buck, M., Gabrielli, B., Parsons, P. G. and Krauer, K. G. (2002). A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus-transformed B-cell lines - A potential therapy for posttransplant lymphoproliferative disease. Transplantation, 73 (2), 271-279. doi: 10.1097/00007890-200201270-00021
Introduction: Molecular and biomechanical basis of osteoarthritis
Pavey, Sandra, Russell, Terry and Gabrielli, Brian (2002). Introduction: Molecular and biomechanical basis of osteoarthritis. Cellular and Molecular Life Sciences, 59 (1), 3-4. doi: 10.1007/s00018-002-8399-5
Loss of p16 expression is associated with histological features of melanoma invasion
Pavey, S. J., Cummings, M. C., Whiteman, D. C., Castellano, M., Walsh, M. D., Gabrielli, B. G., Green, A. and Hayward, N. K. (2002). Loss of p16 expression is associated with histological features of melanoma invasion. Melanoma Research, 12 (6), 539-547. doi: 10.1097/01.cmr.0000043154.28051.9f
Gabrielli, B, Warrener, R, Beamish, H, Burgess, A and Waterhouse, N (2002). Tumor-selective toxicity of histone deacetylase inhibitors is due to their targeting cell cycle checkpoint points. European Journal of Cancer, 38, S95-S95.
Pavey, S. and Gabrielli, B. (2002). alpha-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet irradiation. Cancer Research, 62 (3), 875-880.
G2 phase cell cycle arrest in human skin following UV irradiation
Pavey, Sandra, Russell, Terry and Gabrielli, Brian (2001). G2 phase cell cycle arrest in human skin following UV irradiation. Oncogene, 20 (43), 6103-6110. doi: 10.1038/sj.onc.1204707
Cdc25B activity is regulated by 14-3-3
Forrest, A. and Gabrielli, B. (2001). Cdc25B activity is regulated by 14-3-3. Oncogene, 20 (32), 4393-4401. doi: 10.1038/sj.onc.1204574
Goldstone, S., Pavey, S., Forrest, A., Sinnamon, J. and Gabrielli, B. (2001). Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene, 20 (8), 921-932. doi: 10.1038/sj.onc.1204177
Brinkmann, Hannah, Dahler, Alison L., Popa, Claudia, Serewko, Magdalena M., Parsons, Peter G., Gabrielli, Brian G., Burgess, Andrew J. and Saunders, Nicholas A. (2001). Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts. Journal of Biological Chemistry, 276 (25), 22491-22499. doi: 10.1074/jbc.M100206200
Up-regulation of p21(WAF1)/(CIP1) by histone deacetylase inhibitors reduces their cytotoxicity
Burgess, A. J., Pavey, S., Warrener, R., Hunter, L. J. K., Piva, T. J., Musgrove, E. A., Saunders, N., Parsons, P. G. and Gabrielli, B. G. (2001). Up-regulation of p21(WAF1)/(CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Molecular Pharmacology, 60 (4), 828-837.
Qiu, Ling, Burgess, Andrew, Fairlie, David P., Leonard, Helen, Parsons, Peter G. and Gabrielli, Brian G. (2000). Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Molecular Biology of the Cell, 11 (6), 2069-2083. doi: 10.1091/mbc.11.6.2069
Regulation of CDC25B phosphatases subcellular localization
Davezac, N, Baldin, V, Gabrielli, B, Forrest, A, Theis-Febvre, N, Yashida, M and Ducommun, B (2000). Regulation of CDC25B phosphatases subcellular localization. Oncogene, 19 (18), 2179-2185. doi: 10.1038/sj.onc.1203545
Centrosomal and cytoplasmic Cdc2/Cyclin B1 activation precedes nuclear mitotic events
De Souza, C. P. C., Ellem, K. A. O. and Gabrielli, B. G. (2000). Centrosomal and cytoplasmic Cdc2/Cyclin B1 activation precedes nuclear mitotic events. Experimental Cell Research, 257 (1), 11-21. doi: 10.1006/excr.2000.4872
Multiple splicing variants of cdc25B regulate G2/M progression
Forrest, A. R. R., McCormack, A. K., DeSouza, C. P. C., Sinnamon, J. M., Tonks, I. D., Hayward, N. K., Ellem, K. A. O. and Gabrielli, B. G. (1999). Multiple splicing variants of cdc25B regulate G2/M progression. Biochemical and Biophysical Research Communications, 260 (2), 510-515. doi: 10.1006/bbrc.1999.0870
Gabrielli, B., Sarcevic, B., Sinnamon, J. M., Walker, G. J., Castellano, M., Wang, X. Q. and Ellem, K. (1999). A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay. The Journal of Biological Chemistry, 274 (20), 13961-13969. doi: 10.1074/jbc.274.20.13961
Functional reassessment of p16 variants using a transfection-based assay
Walker, GJ, Gabrielli, BG, Castellano, M and Hayward, NK (1999). Functional reassessment of p16 variants using a transfection-based assay. International Journal of Cancer, 82 (2), 305-312. doi: 10.1002/(SICI)1097-0215(19990719)82:2<305::AID-IJC24>3.0.CO;2-Z
Ultraviolet radiation induces p16CDKN2A expression in human skin
Pavey, S. J., Conroy, S., Russell, T. and Gabrielli, B. (1999). Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Research, 59 (17), 4185-4189.
Involvement of p16(CDKN2A) in cell cycle delays after low dose UV irradiation
Milligan, A, Gabrielli, BG, Clark, JM, Hayward, NK and Ellem, KAO (1998). Involvement of p16(CDKN2A) in cell cycle delays after low dose UV irradiation. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 422 (1), 43-53. doi: 10.1016/S0027-5107(98)00174-2
ATM associates with and phosphorylates p53: Mapping the region of interaction
Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., Taya Y., Gabrielli B., Chan D., Lees-Miller S.P. and Lavin M.F. (1998). ATM associates with and phosphorylates p53: Mapping the region of interaction. Nature Genetics, 20 (4), 398-400. doi: 10.1038/3882
Production of a soluble cyclin B/cdc2 substrate for cdc25 phosphatase
Clark J.M. and Gabrielli B.G. (1997). Production of a soluble cyclin B/cdc2 substrate for cdc25 phosphatase. Analytical Biochemistry, 254 (2), 231-235. doi: 10.1006/abio.1997.2412
Gabrielli B.G., Clark J.M., McCormack A.K. and Ellem K.A.O. (1997). Hyperphosphorylation of the N-terminal domain of cdc25 regulates activity toward cyclin B1/cdc2 but not cyclin A/cdk2. Journal of Biological Chemistry, 272 (45), 28607-28614. doi: 10.1074/jbc.272.45.28607
CDKN2A/p16 is inactivated in most melanoma cell lines
Castellano, M, Pollock, PM, Walters, MK, Sparrow, LE, Down, LM, Gabrielli, BG, Parsons, PG and Hayward, NK (1997). CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Research, 57 (21), 4868-4875.
Dong, Y, Walsh, MD, McGuckin, MA, Cummings, MC, Gabrielli, BG, Wright, GR, Hurst, T, Khoo, SK and Parsons, PG (1997). Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer, 74 (4), 407-415. doi: 10.1002/(SICI)1097-0215(19970822)74:4<407::AID-IJC8>3.0.CO;2-Z
Gabrielli, BG, Clark, JM, McCormack, AK and Ellem, KAO (1997). Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene, 15 (7), 749-758. doi: 10.1038/sj.onc.1201254
Castellano, M, Gabrielli, BG, Hussussian, CJ, Dracopoli, NC and Hayward, NK (1997). Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal. Journal of Investigative Dermatology, 109 (1), 61-68. doi: 10.1111/1523-1747.ep12276538
Dong, Y, Walsh, MD, McGuckin, MA, Gabrielli, BG, Cummings, MC, Wright, RC, Hurst, T, Khoo, SK and Parsons, PG (1997). Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer, 74 (1), 57-63. doi: 10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F
Wang, XQ, Gabrielli, BG, Milligan, A, Dickinson, JL, Antalis, TM and Ellem, KAO (1996). Accumulation of p16(CDKN2A) in response to ultraviolet irradiation correlates with a late S-G(2)-phase cell cycle delay. Cancer Research, 56 (11), 2510-2514.
Gabrielli, BG, DeSouza, CPC, Tonks, ID, Clark, JM, Hayward, NK and Ellem, KAO (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. Journal of Cell Science, 109 (5), 1081-1093.
De Souza, C. P.C., Gabrielli, B. C., Clark, J. M. and Ellem, K. A.O. (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. Biochemical Society Transactions, 24 (4)
Purification of a serine kinase that associates with and phosphorylates human Cdc25C on serine 216
Ogg, Scott, Gabrielli, Brian and Piwnica-Worms, Helen (1994). Purification of a serine kinase that associates with and phosphorylates human Cdc25C on serine 216. Journal of Biological Chemistry, 269 (48), 30461-30469.
Cell cycle regulation of the p34cdc2 inhibitory kinases
Atherton-Fessler, Sue, Liu, Feng, Gabrielli, Brian, Lee, Margaret S., Peng, Cheng-Yuan and Piwnica-Worms, Helen (1994). Cell cycle regulation of the p34cdc2 inhibitory kinases. Molecular Biology of the Cell, 5 (9), 989-1001. doi: 10.1091/mbc.5.9.989
Morrice, Nicholas A., Gabrielli, Brian, Kemp, Bruce E. and Wettenhall, Richard E. H. (1994). A cardiolipin-activated protein kinase from rat liver structurally distinct from the protein kinases C. Journal of Biological Chemistry, 269 (31), 20040-20046.
Requirement for Cdk2 in Cytostatic Factor Mediated Metaphase-Ii Arrest
Gabrielli, BG, Roy, LM and Maller, JL (1993). Requirement for Cdk2 in Cytostatic Factor Mediated Metaphase-Ii Arrest. Science, 259 (5102), 1766-1769. doi: 10.1126/science.8456304
Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex
Gabrielli, Brian G., Lee, Margaret S., Walker, Duncan H., Piwnicaworms, Helen and Maller, James L. (1992). Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. Journal of Biological Chemistry, 267 (25), 18040-18046.
A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2
Gabrielli, Brian G., Roy, Linda M., Gautier, Jean, Philippe, Michel and Maller, James L. (1992). A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2. Journal of Biological Chemistry, 267 (3), 1969-1975.
Activation of p34cdc2 kinase by cyclin A
Roy, L. M., Swenson, K. I., Walker, D. H., Gabrielli, B. G., Li, R. S., Piwnicaworms, H. and Maller, J. L. (1991). Activation of p34cdc2 kinase by cyclin A. Journal of Cell Biology, 113 (3), 507-514. doi: 10.1083/jcb.113.3.507
Wettenhall, R. E., Gabrielli, B., Morrice, N., Bozinova, L., Kemp, B. E. and Stapleton, D. (1991). Determinants of multi-site phosphorylation of peptide analogues of ribosomal protein S6 by novel protease-activated protein kinases. Peptide research, 4 (3), 158-170.
Gabrielli, B, Wettenhall, Reh, Kemp, BE, Quinn, M and Bizonova, L (1984). Phosphorylation of Ribosomal Protein-S6 and a Peptide Analog of S6 by a Protease-Activated Kinase Isolated From Rat-Liver. Febs Letters, 175 (2), 219-226. doi: 10.1016/0014-5793(84)80740-1
Andrews, Ariel, Kumar, Ramyashree Prasanna, Nazareth, Deborah, Ehmann, Anna, Hooper, John, McMillan, Nigel and Gabrielli, Brian (2019). Inhibition of Aurora B kinase activity triggers senescence that can be bypassed by blocking p53 and RB function, promoting replication stress. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, MA USA, 26-30 October 2019. Philadelphia, PA USA: American Association for Cancer Research. doi: 10.1158/1535-7163.TARG-19-A060
Bortezomib-induced immunogenic cell death enhances immune response in melanoma
Daignault, S. M., Ju, R., Spoerri, L., Stehbens, S. J., Hill, D. S., Gabrielli, B., Dolcetti, R. and Haass, N. K. (2019). Bortezomib-induced immunogenic cell death enhances immune response in melanoma. Society for Investigative Dermatology (SID) Meeting, Chicago, IL United States, 8-11 May 2019. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2019.03.907
Oo, Zay Yar, Proctor, Martina, Stevenson, Alex, Nazareth, Deborah, Larsen, Jill, Haass, Nikolas and Gabrielli, Brian G. (2019). Subclinical doses and choice of replication stress inducer in combination with CHK1 inhibitors for optimal tumor control and immune responses in vitro and in vivo. AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology, Atlanta Ga, Mar 29-Apr 03, 2019. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2019-1236
Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma
Emran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815
Overexpression of the cell cycle regulator Emi1 promotes chromosome instability and tumorigenesis
Duijf, Pascal H. G., Vaidyanathan, Srividya, Cato, Kathleen, Thangavelu, Pulari U., Lin, Cheng-Yu, Tang, Lu, Pavey, Sandra, Haass, Nikolas K. and Gabrielli, Brian G. (2018). Overexpression of the cell cycle regulator Emi1 promotes chromosome instability and tumorigenesis. 76th Annual Meeting of the Japanese Cancer Association, Yokohama, Japan, 28-30 September 2017. Tokyo, Japan: Wiley Japan. doi: 10.1111/cas.13499
Targeting cell cycle phase-specific drug sensitivity for melanoma therapy
Daignault, S. M., Hill, D. S., Spoerri, L., Stehbens, S., Weninger, W., Gabrielli, B., Dolcetti, R. and Haass, N. K. (2018). Targeting cell cycle phase-specific drug sensitivity for melanoma therapy. 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF), Zurich, Switzerland, 7-10 March 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities
Haass, N., Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Daignault, S. M., Gabrielli, B. and Weninger, W. (2017). Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities. Australasian College of Dermatologists 50th Annual Scientific Meeting, International Convention Centre, Sydney, NSW Australia, 6-9 May 2017. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.20_12652
Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells
Beaumont, K., Hill, D., Daignault, S., Sharp, D., Gabrielli, B., Weninger, W. and Haass, N. (2016). Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells. Annual Meeting of the Society-for-Investigative-Dermatology (SID), Scottsdale, AZ, United States, 11-14 May 2016. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2016.02.695
Global histone modifications define early stress induced drug tolerance in cancer
Al Emran, Abdullah, Menon, Dinoop Ravindran, Soyer, Peter, Gabrielli, Brian, Sturm, Rick, Herlyn, Meenhard and Schaider, Helmut (2016). Global histone modifications define early stress induced drug tolerance in cancer. American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA, United States, 24-27 September 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.CHROMEPI15-B34
Inhibition of Aurora Kinases is curative for HPV-driven tumours
McMillan, N., Fallaha, S., Martin, D., Leggatt, G. and Gabrielli, B. (2016). Inhibition of Aurora Kinases is curative for HPV-driven tumours. 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal, 28-31 October 2016. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.IGC.0000503327.50238.5c
Gabrielli, Brian G., Bokhari, Fawzi, Ranall, Max, Oo, Zay Yar, Stevenson, Alex, Wang, Weili, McKee, Sara, Leggatt, Graham, Leo, Paul, Gonda, Thomas J. and McMillan, Nigel A. J. (2015). Abstract 945: synthetic lethal screen identifies Aurora A as a selective target in HPV driven cervical cancer. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA United States, 18-22 April 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-945
Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicity
Hill, D. S., Beaumont, K. A., Daignault, S. M., Anfosso, A., Sharp, D. M., Gabrielli, B., Lovat, P. E., Weninger, W. and Haass, N. K. (2015). Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicity. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, Mar 05-07, 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623
Synthetic lethal screen identifies Aurora A as a selective target in HPV driven cervical cancer
Gabrielli, B., Bokhari, F., Ranall, M., Stevenson, A., Murell, M., Kelly, M., McKee, S., Leggatt, G., Gonda, T. and McMillan, N. (2014). Synthetic lethal screen identifies Aurora A as a selective target in HPV driven cervical cancer. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, 18-21 November 2014. Abingdon, Oxford, United Kingdom: Elsevier. doi: 10.1016/S0959-8049(14)70420-4
Chk1 inhibitor targets replicative stress in melanomas
Gabrielli, Brian G., Brooks, Kelly, Edwards, Brooke, Chen, James and Pavey, Sandra (2013). Chk1 inhibitor targets replicative stress in melanomas. 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington Dc, Apr 06-10, 2013. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2013-3425
Lee, W. J., Skalamera, D., Dahmer, M., Shakhbazov, K., Purdon, A., Wilson, B., Ranall, M, Pinder, A., Pavey, S., Gonda, T. and Gabrielli, B. (2012). A Genome-wide Human ORF Gain-of-function Screen to Identify Genes that can Bypass p16INK4a-mediated Cellular Senescence. 6th Australian High Content Screening Group Meeting, Melbourne, Australia, 13th July 2012.
Chk1 inhibitor targets replicative stress in melanomas
Gabrielli, B., Brooks, K., Oakes, V., Edwards, B., Chen, J. and Mukhopadhyay, P. (2012). Chk1 inhibitor targets replicative stress in melanomas. 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin Ireland, 6-9 November 2012. Oxford, United Kingdom: Pergamon. doi: 10.1158/1538-7445.AM2013-3425
Wigan, Matthew, Pavey, Sandra, Brooks, Kelly, Giles, Nichole, Burgess, Andrew, Sturm, Rick and Gabrielli, Brian (2011). Abstract 4197: A DNA damage checkpoint response to unrepaired ultraviolet radiation-induced lesions which is defective in melanoma. AACR 102nd Annual Meeting 2011, Orlando, FL United States, 2‐6 April 2011. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2011-4197
Lee, W. J., Skalamera, D., Dahmer, M., Shakhbazov, K., Ranall, M., Purdon, A., Wilson, B., Pinder, A., Pavey, S., Gonda, T. and Gabrielli, B. (2011). A functional genomics approach to identify genes and pathways that can bypass p16INK4a-mediated cellular senescence. 14th Annual Australian Cell Cycle Workshop, Noosa, Australia, 24 October 2011.
Lee, W. J., Skalamera, D. and Gabrielli, B. (2011). A high-coverage and high-content human ORF overexpression screen to identify pathways that can bypass p16INK4a-mediated cellular senescence. 5th Australian High Content Screening Group Meeting, Melbourme, Australia, 15 July 2011.
Skoien, R., Powell, E. E., Melino, M., Clouston, A. D., Gabrielli, B. G. and Jonsson, J. R. (2010). Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis. Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/j.1440-1746.2010.06450.x
Wigan, M., Giles, N., Pavey, S. and Gabrielli, B. (2009). Suberythemal UV G2 phase checkpoint in response to post replication repair is defective in a majority of melanoma cell lines. 5th Annual Scientific Meeting of the Australasian Society for Dermatology Research, Sydney, Australia, 21-22 May 2008. United Kingdom: Nature Publishing Group. doi: 10.1038/jid.2009.333
UVR induced ERK signaling pathway regulates p16 expression in skin
Giles, N., Pavey, S. and Gabrielli, B (2009). UVR induced ERK signaling pathway regulates p16 expression in skin. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney, Australia, 21-22 May 2008. United Kingdom: Nature Publishing Group. doi: 10.1038/jid.2009.333
(2023–2026) Ovarian Cancer Research Foundation Research Grants
Enhancing tumour immune detection by targeting replication stress
(2021–2024) Established Investigator
(2018–2020) TRI Spore Grants
Preclinical development of combinations with CHK1 inhibitors in melanoma and lung cancer
(2018–2019) Cancer Council Queensland
(2016–2019) Griffith University
Epigenetic remodelling driving acquired permanent drug resistance in melanoma cells
(2016) PA Research Foundation
(2015–2018) NHMRC Project Grant
(2015–2016) Griffith University
(2015) NHMRC Equipment Grant
Targeting HPV in oropharyngeal cancers
(2015) PA Research Foundation
(2014–2016) NHMRC Project Grant
Calibration of single channel and liquid handling robots
(2014) UQ Major Equipment and Infrastructure
Purchase of low O2 incubator and Dissociator
(2014) NHMRC Equipment Grant
(2013–2015) Garvan Institute
Functional characterization of the regulatory architecture of melanoma-associated loci
(2013) NHMRC Project Grant
(2012–2015) University of Melbourne
Functional assessment of new melanoma genomic mutations
(2012–2015) Worldwide Cancer Research
Synthetic lethality screen targeting a defective checkpoint in melanoma
(2012–2015) NHMRC Project Grant
Defining a response to UV exposure that is defective in melanoma
(2012–2013) Cancer Council Queensland
Validation of genes potentially involved in early stage melanoma using immunohistochemistry
(2012) Queensland Pharmacy Research Trust
Laser Scanner for Biomolecular Imaging
(2011) NHMRC Equipment Grant
Targeting the G2 phase checkpoint in Glioblastoma to improve the efficacy of current therapy
(2011) Brain Foundation
NHMRC Research Fellowship: Senior Research Fellowship A
(2010–2015) NHMRC Research Fellowship
Synthetic lethality screen targeting a defective checkpoint in melanoma
(2010–2012) Cancer Council Queensland
Centrosome overduplication contributes to tumorigenesis
(2010) NHMRC Project Grant
The role of tumour-initiating cells in glioma
(2009–2012) NHMRC Project Grant
Proteomic studies in cancer, immunology and metabolism research
(2009) UQ Institute Co-Funding
(2008–2009) Cancer Council Queensland
Is the heterochromatin checkpoint a useful anti-cancer drug target?
(2008–2009) Cancer Council Queensland
(2008) UQ Major Equipment and Infrastructure
CDK4 activity in S/G2 phases influences mitotic fidelity
(2007–2009) NHMRC Project Grant
The function of truncated MEK1 in a G2 phase cell cycle delay and in mitosis
(2007–2009) ARC Discovery Projects
Transcriptional complexity of cell cycle regulated genes during cell division and tumorigenesis
(2007–2009) NHMRC Project Grant
The molecular basis for the initiation of squamous differentiation
(2006–2007) Queensland Cancer Fund
(2006) ARC Linkage Infrastructure, Equipment and Facilities
NHMRC SENIOR RESEARCH FELLOWSHIP
(2005–2009) NHMRC Research Fellowship
(2005–2006) Queensland Cancer Fund
Function of the unique mitotic form of MEK
(2004–2006) ARC Discovery Projects
Histone Hyperacetylation Affects G2/M Cell Cycle Transition
(2004–2006) NHMRC Project Grant
(2004–2006) NHMRC Project Grant
Mechanism of UV Induction of the Melanoma Susceptibility Gene Product P16CDKN2A in Skin
(2003–2004) Queensland Cancer Fund
Zeiss Cell Observer Video Microscopy System
(2003) NHMRC Equipment Grant
Mitotic regulation of the Ras/Raf/MEK/ERK pathway
(2002–2003) Queensland Cancer Fund
(2001–2002) NHMRC Equipment Grant
(2000–2001) UQ New Staff Research Start-Up Fund
AURKi enhances replication stress targeted by CHK1i in p53 and RB defective cells
Doctor Philosophy — Principal Advisor
Epigenomic determinants of chemotherapy response in triple-negative breast cancer
Doctor Philosophy — Associate Advisor
Other advisors:
Modulating phenotypic melanoma heterogeneity and lymphocyte infiltration to improve both targeted and immune therapy
Doctor Philosophy — Associate Advisor
Other advisors:
Assessment of cell cycle phase-dependent immunogenicity of melanoma treated with the proteasome inhibitor bortezomib
Doctor Philosophy — Associate Advisor
Other advisors:
Targeting DNA Damage Response Defects in Cancers
(2022) Doctor Philosophy — Principal Advisor
The Role of Microenvironment in Development of Skin Cancer and Metastasis
(2018) Doctor Philosophy — Principal Advisor
Mechanisms and markers of CHK1 inhibitors sensitivity in melanoma
(2017) Doctor Philosophy — Principal Advisor
Other advisors:
Identifying molecular changes in naevi driving early stage melanoma
(2014) Master Philosophy — Principal Advisor
Other advisors:
(2014) Doctor Philosophy — Principal Advisor
Investigating the Mode of Action of Histone Deacetylase Inhibiting Agents
(2012) Doctor Philosophy — Principal Advisor
Selective targeting of the defective decatenaion checkpoint in melanoma
(2012) Doctor Philosophy — Principal Advisor
The role of MEK1 in progression through G2/M phase of the cell cycle.
(2011) Doctor Philosophy — Principal Advisor
Regulation of Cdc25B during G2/M progression
(2010) Doctor Philosophy — Principal Advisor
Investigating The Mechanism Involved In Regulating Ultraviolet Radiation Induced P16 Expression
(2008) Master Philosophy — Principal Advisor
TARGETING CELL CYCLE CHECKPOINTS TO SPECIFICALLY KILL CANCER
(2004) Doctor Philosophy — Principal Advisor
Distinct Epigenetic Modifications Denote Early Drug Resistance in Cancer
(2018) Doctor Philosophy — Joint Principal Advisor
Other advisors:
(2018) Doctor Philosophy — Associate Advisor
(2016) Doctor Philosophy — Associate Advisor
Other advisors:
Functional Characterisation of the Cyclin Dependent Kinase-Like 3 Isoforms
(2014) Doctor Philosophy — Associate Advisor
Protein Arginine Methyltransferase 6 regulates transcription and alternative splicing
(2011) Doctor Philosophy — Associate Advisor
(2008) Doctor Philosophy — Associate Advisor
FUNCTIONAL GENOMICS OF THE PROTEIN KINASES AND PHOTOPHATASES OF MOUSE
(2006) Doctor Philosophy — Associate Advisor
Other advisors:
Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.
Identifying the molecular basis for defective checkpoints in melanoma
Targeting defective cell cycle responses to ultraviolet radiation and TopoII inhibitors in melanoma
Defining the molecular changes in moles underpinning morphological changes detectable by non-invasive imaging techniques to improve their diagnostic and prognostic ability for early stage melanoma